EPHB4 and erythema multiforme: Notably, previous studies have reported that inhibition of EPHB4 expression leads to a significant decrease in the number of proliferating stromal cells and a slower growth of ectopic lesions (38), suggesting that EPHB4 may be a promising therapeutic target for EM.